<i>ANGPTL6</i> Genetic Variants Are an Underlying Cause of Familial Intracranial Aneurysms.

Abstract

To understand the role of the angiopoietin-like 6 gene (<i>ANGPTL6</i>) in intracranial aneurysms (IAs), we investigated its role in a large cohort of familial IAs. Individuals with family history of IA were recruited to the Genetic and Observational Subarachnoid Haemorrhage (GOSH) study. The <i>ANGPTL6</i> gene was sequenced using Sanger sequencing. Identified genetic variants were compared to a control population. We found 6 rare <i>ANGPTL6</i> genetic variants in 9/275 individuals with a family history of IA (3.3%) (5 missense mutations and 1 nonsense mutation leading to a premature stop codon), none present in controls. One of these had been previously reported: c.392A>T (p.Glu131Val) on exon 2; another was very close: c.332G>A (p.Arg111His). Two further genetic variants lie within the fibrinogen-like domain of the <i>ANGPTL6</i> gene, which may influence function or level of the ANGPTL6 protein. The last 2 missense mutations lie within the coiled-coil domain of the ANGPTL6 protein. All genetic variants were well conserved across species. <i>ANGPTL6</i> genetic variants are an important cause of IA. Defective or lack of ANGPTL6 protein is therefore an important factor in blood vessel proliferation leading to IA; dysfunction of this protein is likely to cause abnormal proliferation or weakness of vessel walls. With these data, not only do we emphasize the importance of screening familial IA cases for <i>ANGPTL6</i> and other genes involved in IA, but also highlight the ANGPTL6 pathway as a potential therapeutic target. This is a Class III study showing some specificity of presence of the <i>ANGPTL6</i> gene variant as a marker of familial intracranial aneurysms in a small subset of individuals with familial aneurysms.